Operating

Alnylam Pharmaceuticals·Cash Flow Statement·13 metrics

Breakdown

Loading...

Metrics

Change in accounts payable

Change in accounts receivable

Change in deferred revenue

Change in inventories

Change in other assets

Other working capital changes

Depreciation and amortization

Net gains (losses) on investments

Net cash from operating activities

Net income

Non-cash interest expense on liabilities related to the sale of future royalties and development funding

Non-cash interest expense on liabilities related to the sale of future royalties and development funding

Stock-based compensation